Alpers disease
(Redirected from Progressive sclerosing poliodystrophy)
Alpers disease | |
---|---|
ICD-10 | |
ICD-9 | |
DiseasesDB | |
MedlinePlus | |
eMedicine | |
MeSH ID |
Alpers' disease, also known as Alpers-Huttenlocher syndrome, is a rare neurodegenerative disorder that primarily affects the central nervous system. It is characterized by seizures, developmental delay, and liver dysfunction.
Causes[edit | edit source]
Alpers' disease is caused by mutations in the POLG gene, which is responsible for encoding the DNA polymerase gamma enzyme. This enzyme is crucial for the replication and repair of mitochondrial DNA. Mutations in the POLG gene lead to mitochondrial dysfunction, which is the underlying cause of the symptoms observed in Alpers' disease.
Symptoms[edit | edit source]
The symptoms of Alpers' disease typically begin in infancy or early childhood. Common symptoms include:
As the disease progresses, affected individuals may experience liver failure and severe neurological impairment.
Diagnosis[edit | edit source]
Diagnosis of Alpers' disease involves a combination of clinical evaluation and genetic testing. Neurologists may suspect the disease based on the clinical presentation and family history. Genetic testing can confirm the presence of mutations in the POLG gene.
Treatment[edit | edit source]
There is currently no cure for Alpers' disease. Treatment is primarily supportive care aimed at managing symptoms and improving quality of life. Antiepileptic drugs may be used to control seizures, although they may not be effective in all cases. Liver transplantation may be considered in cases of severe liver failure, but the progressive neurological decline often limits the overall prognosis.
Prognosis[edit | edit source]
The prognosis for individuals with Alpers' disease is generally poor. The disease is progressive, and most affected individuals do not survive beyond childhood. The severity and progression of symptoms can vary, but the condition is ultimately life-limiting.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD, Dr.T